Genertec Universal Medical Group Company Limited (Genertec Universal Medical) announced that all motions tabled at its Annual General Meeting (AGM) on 24 June 2026 were approved by poll, underscoring broad shareholder support for the board’s proposals.
Dividend Payout • Shareholders endorsed a final dividend of HK$0.36 per share for FY 2025. Based on the 2.01 billion shares in issue as at the meeting date, the payout equates to approximately HK$0.73 billion.
Board & Governance Resolutions • The FY 2025 audited financial statements and directors’ and auditors’ reports were adopted with 99.95% of votes in favour. • All five directors standing for re-election—Xia Qi, Tong Chaoyin, Huang Youjie, Ma Wanming and Li Yinquan—were returned, receiving support levels ranging from 95.93% to 99.28%. • Director remuneration authority (99.91% support) and the re-appointment of SHINEWING (HK) CPA Limited as external auditor (100.00% support) were both confirmed. • Share buy-back and share-issue mandates passed with 100.00% and 89.90% support, respectively. The related mandate extension garnered 90.42% approval. • A special resolution to amend the company’s articles of association was backed by 97.89% of votes cast.
Connected Transaction – Procurement Framework • Independent shareholders approved the revised annual cap for FY 2026 under the Medical Related Product Procurement Framework Agreement with 100.00% support (494.17 million votes for, 12,500 against). Controlling shareholder China General Technology (Group) Holding Company Limited and its subsidiaries, holding 37.66% of issued shares, abstained from voting in line with listing rules.
Voting and Attendance • Of the 2.01 billion shares outstanding, 1.26 billion shares were eligible to vote on the connected-transaction resolution, while all shares were entitled to vote on the remaining items. • The AGM was attended in person or via video conference by all board members. Computershare Hong Kong Investor Services Limited acted as scrutineer.
The comprehensive approval of every resolution, including capital mandates and governance changes, provides Genertec Universal Medical with flexibility for future corporate actions and confirms shareholder confidence in the company’s strategic direction.
Comments